Morgan Stanley Downgrades Teva Pharma (TEVA) to Equalweight
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $37.45 +2.38%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
Morgan Stanley downgraded Teva Pharma (NASDAQ: TEVA) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $45.71 yesterday.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $45.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Diamondback Energy (FANG) to Equalweight
- Morgan Stanley Downgrades Baidu (BIDU) to Underweight
- JPMorgan Downgrades Klarna (KLAR) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
